Neurocrine Biosciences, Inc. (BIT:1NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,570	13,349	11,712	10,744	7,105	7,321
Market Cap Growth	13.98%	13.98%	9.01%	51.23%	-2.96%	-17.01%
Enterprise Value	9,058	12,439	10,969	10,261	6,829	6,972
PE Ratio	29.03	40.49	51.85	74.32	90.18	21.99
PS Ratio	4.21	5.87	6.86	7.71	7.13	8.56
PB Ratio	3.83	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	3.89	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	-	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	-	23.21	33.20	33.83	31.50	39.19
EV/Sales Ratio	4.36	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	15.76	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	17.62	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	16.83	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.19	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.89	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.68	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	15.99	15.99	16.48	14.85	11.71	12.59
Quick Ratio	3.06	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.40	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.16%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	10.46%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	12.68%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	18.20%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	3.44%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	5.62%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	-2.67%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.